BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2021
View Archived Issues
YAP/TEAD expression defines distinct vulnerabilities in binary pan-cancer groups
Read More
Phase II topline data show efficacy of MS-1819 plus PERT in severe exocrine pancreatic insufficiency
Read More
DSG3-CAART cells safe in second cohort of DesCAARTes phase I trial
Read More
Brexpiprazole does not meet primary endpoint in borderline personality disorder trial
Read More
Assembly Biosciences to advance anti-HBV agent ABI-4334 to the clinic
Read More
Eisai describes new compounds for malaria
Read More
Roche discloses new antibacterials
Read More
Phenex Pharmaceuticals presents new AhR antagonists
Read More
New anti-MDR1 antibodies discovered by Kenjockety Biotechnology
Read More
Green light for UB-421 phase II studies in Taiwan and China for HIV
Read More
TCF7L2 gene variants linked to thoracic aortic aneurysm
Read More
APVO-436 may benefit patients with AML and MDS, first-in-human data suggest
Read More
First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction
Read More
Viral-trapping icosahedral shells devised as broad-spectrum antiviral platform
Read More
TT-00420 enters phase I/II trial for advanced solid tumors
Read More
"Not just the flu" holds for SARS-CoV-2 long-term effects, too
Read More
Well Marker Bio starts phase I study of WM-S1-030 for solid tumors
Read More
COM-902 derivative AZD-2936 enters the clinic for non-small cell lung cancer
Read More